Home Products Most Popular Contact
No items in your cart.
The page below is a sample from the LabCE course Hallmarks and Signaling of Cancer Cells. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Hallmarks and Signaling of Cancer Cells (online CE course) »
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 111 CE courses, most popular
$95 Add to cart
Pick Your Courses
Up to 8 CE hours
$50 Add to cart
Individual course$20 Add to cart

References

Bertolini F. Drug repurposing in oncology: patient and health systems opportunities. Nat. Rev Clinical Oncol. 2015;Volume12:732-742.
Burn J. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomized controlled trial . Lancet. 2011;Volume378:2081-2087.
Cancer Society TA. Immune checkpoint inhibitors to treat cancer. cancer.org. http://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/immunotherapy/immune-checkpoint-inhibitors.html#written_by. July 23, 2015. May 1, 2017. Last accessed March 27, 2018.
Cohler J. Afatinib, erlotinib, and gefitinib in the first of therapy of EGFR mutation-positive lung adenocarcinoma: a review. Onkologie. 2013;Volume36:510-518.
Fang Y. Three-Dimensional Cell Cultures in Drug Discovery and Development. SLAS Discovery. 2017;Volume22:456-472.
Ganapathy V. TGFb prevents proteasomal degradation of the cyclin-dependent kinase inhibitor p27kip1 for cell cycle arrest. Cell Cycle. 2009;Volume8:742-756.
Hanahan D. The hallmarks of cancer. Cell. 2000;Volume100:447-458.
Hanahan D. Hallmarks of cancer: The next generation. Cell. 2010;Volume400:456-472.
Kong D. Aspirin in cardiovascular disorders. What is the optimal dose?. Am. J. Cardiovasc Drugs. 2004;Volume4:151-158.
Labak C. Glucose transport: meeting the metabolic demands of cancer, and replications in glioblastoma treatment. Am. J. Cancer Research. 2016;Volume6:1599-1608.
Morris T. Effects of low dose aspirin on acute inflammatory response in humans. . Am. J. Cardiovasc Drugs. 2009;Volume183:2089-2096.
Neyzillet C. Targeting the TGFbeta pathway for cancer therapy. Pharmacology & Therapeutics. 2015;Volume147:22-31.
Padua D. Roles of TGFbeta in metastasis. Cell Research. 2009;Volume19:89-102.
Sparmann A. Ras-induced interleukin-8 plays a critical role in tumor growth and metastasis. Cancer Cell. 2004;Volume6:447-458.
Tougeron D. Aspirin and colorectal cancer: Back to the Future. Clin Cancer Res,. 2014;Volume20:1087-1094.